logo
logo

Twin Strand Biosciences, Inc. announced it raised $50 Million in an initial filing from an offering of $50 Million

May 12, 2021about 4 years ago

Amount Raised

$50 Million

SeattleInformation Technology

Company Information

Company

TwinStrand Biosciences, Inc.

Location

3131 ELLIOTT AVENUE

Seattle, Washington, United States

About

We are a vibrant young company committed to science first. Our mission is to develop and deliver the unprecedented accuracy of TwinStrand Duplex Sequencing™ technology for applications in clinical medicine and life sciences where it can do the greatest good for the greatest number of people. Our approach is multifaceted and encompasses internal development projects, external collaborations and empowering of partner organizations. TwinStrand Duplex Sequencing™ technology is an ultra-high accuracy, error-corrected sequencing method that overcomes the limitations of NGS by independently tracking both strands of individual DNA molecules. Utilizing our multi-patented novel chemistry and cloud-based bioinformatics, the paired sequences are compared to eliminate errors, reducing error rates from 1-in-100 to 1-in-10 million, revealing ultra-low frequency variants.

FundzWatch™ Score

63
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People